Preclinical evaluation of pharmacokinetics and safety of melatonin in propylene glycol for intravenous administration.
about
Melatonin protects liver from intestine ischemia reperfusion injury in ratsNeuroprotective effect of melatonin against kainic acid-induced oxidative injury in hippocampal slice culture of rats.Antiinflammatory activity of melatonin in central nervous systemA validated sensitive HPLC-MS/MS method for quantification of a potential hypnotic drug MT502 and its application to a pharmacokinetic study in rat.Melatonin suppresses cisplatin-induced nephrotoxicity via activation of Nrf-2/HO-1 pathway.Effects of melatonin in experimental stroke models in acute, sub-acute, and chronic stagesMelatonin and reproduction revisited.A review of melatonin in hepatic ischemia/reperfusion injury and clinical liver disease.A review of melatonin as a suitable antioxidant against myocardial ischemia-reperfusion injury and clinical heart diseases.Beneficial effects montelukast, cysteinyl-leukotriene receptor antagonist, on renal damage after unilateral ureteral obstruction in rats.Protection of melatonin in experimental models of newborn hypoxic-ischemic brain injury through MT1 receptor.Dual effects of melatonin on oxidative stress after surgical brain injury in rats.Pomegranate extract attenuates unilateral ureteral obstruction-induced renal damage by reducing oxidative stress.Melatonin augments hypothermic neuroprotection in a perinatal asphyxia model.Melatonin protects against amyloid-β-induced impairments of hippocampal LTP and spatial learning in rats.Melatonin ameliorates endothelial dysfunction, vascular inflammation, and systemic hypertension in rats with chronic intermittent hypoxia.Melatonin attenuates traumatic brain injury-induced inflammation: a possible role for mitophagy.Melatonin decreases mortality following severe subarachnoid hemorrhage.Melatonin attenuates phenytoin sodium-induced DNA damage.Melatonin as an Anti-Inflammatory Agent Modulating Inflammasome Activation.Melatonin attenuates inflammatory response-induced brain edema in early brain injury following a subarachnoid hemorrhage: a possible role for the regulation of pro-inflammatory cytokines.Evidence that membrane-bound G protein-coupled melatonin receptors MT1 and MT2 are not involved in the neuroprotective effects of melatonin in focal cerebral ischemia.Melatonin-enhanced autophagy protects against neural apoptosis via a mitochondrial pathway in early brain injury following a subarachnoid hemorrhage.Melatonin attenuated early brain injury induced by subarachnoid hemorrhage via regulating NLRP3 inflammasome and apoptosis signaling.Melatonin attenuates neurogenic pulmonary edema via the regulation of inflammation and apoptosis after subarachnoid hemorrhage in rats.Autophagy in Traumatic Brain Injury: A New Target for Therapeutic Intervention.
P2860
Q33396008-B6C1DD78-14CE-4801-872D-01DC48AAE7EAQ33580540-504A64CD-71D3-479C-B3D2-122356758905Q34402174-1825DD18-9634-4719-AF56-E2324D187D20Q35569688-EF774F0A-18F1-43BC-8877-2BBEB89F190EQ36578703-88200DCD-01FE-47A7-AF1B-E237F9294503Q37224612-EA623C24-8344-4434-B535-D6363A71A18FQ37480368-AC3F7ABE-87F7-4A36-95FD-09D2A1542DBDQ38230663-645A26F7-224E-4EED-A749-EB46660D4253Q38250438-2CB1C69A-833F-4374-91B8-E812234B30E2Q38392076-C15E68F0-1EB1-4AF7-B053-EB13A0401CA1Q38630639-7E468FB6-B463-4C40-9751-9B0FD8CD74EEQ41854597-374D63C6-6085-4611-A677-E472ED559DAAQ41967050-9383312B-EEB1-4326-B9AA-9E8ECFC7580FQ44099805-29561E13-7F57-45F1-8CCC-55D9446EE1A5Q45896609-8CC8F83D-298B-449A-9945-E6DC7DF5B5EFQ45975698-D4B36591-F270-4CFD-9C8F-A85153AA41ABQ46557476-C6CBFBCF-BA96-4193-8437-233CDE1ECB0DQ46742267-7E1CB4D4-3F30-4D35-802B-6DC0520F2683Q46977123-3C4325C0-1FCD-453A-AFD9-F5554D5606C7Q47098709-5F25D7C6-F77D-454D-A575-BBC94CC6D65EQ48565372-208DC208-D8D6-4656-8C65-E3AE9BFBE476Q48902471-E85DD338-A6EF-473C-9ED1-0A46C3B457C9Q49036800-49C8E37A-7179-4612-A2E0-1FBBF78F61A9Q51617151-9CD63EAE-749A-4CAA-90E1-61690F9C2427Q52663659-65FF771F-C49E-4465-9DE2-1D302AB5CFE1Q55228013-B867DB4F-0B80-4B40-9421-4156E4141A1A
P2860
Preclinical evaluation of pharmacokinetics and safety of melatonin in propylene glycol for intravenous administration.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Preclinical evaluation of phar ...... or intravenous administration.
@ast
Preclinical evaluation of phar ...... or intravenous administration.
@en
type
label
Preclinical evaluation of phar ...... or intravenous administration.
@ast
Preclinical evaluation of phar ...... or intravenous administration.
@en
prefLabel
Preclinical evaluation of phar ...... or intravenous administration.
@ast
Preclinical evaluation of phar ...... or intravenous administration.
@en
P2093
P2860
P1476
Preclinical evaluation of phar ...... or intravenous administration.
@en
P2093
Edmond Shiu Kwan Ma
George L Tipoe
Liang Yu Zou
Pui Shan Chan
Raymond Tak Fai Cheung
Sidney Tam
P2860
P304
P356
10.1111/J.1600-079X.2006.00372.X
P577
2006-11-01T00:00:00Z